VTYX - Ventyx Biosciences GAAP EPS of -$0.91 misses by $0.20 August, 10 2023 04:50 PM Ventyx Biosciences Inc. 2023-08-10 16:50:27 ET Ventyx Biosciences press release ( NASDAQ: VTYX ): Q2 GAAP EPS of -$0.91 misses by $0.20 . Cash, cash equivalents and marketable securities were $332.3 million as of June 30, 2023. For further details see: Ventyx Biosciences GAAP EPS of -$0.91 misses by $0.20